Announcements
- Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery Program
- Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology
- Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program
- Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
- Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ
- Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024
- Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024
- Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
More ▼
Key statistics
As of last trade, Asensus Surgical Inc (2TX:DEU) traded at 0.302, 67.78% above the 52 week low of 0.18 set on Jun 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.2996 |
---|---|
High | 0.322 |
Low | 0.298 |
Bid | 0.2968 |
Offer | 0.327 |
Previous close | 0.311 |
Average volume | 12.09k |
---|---|
Shares outstanding | 272.62m |
Free float | 266.99m |
P/E (TTM) | -- |
Market cap | 91.98m USD |
EPS (TTM) | -0.3065 USD |
Data delayed at least 15 minutes, as of Jul 25 2024.
More ▼